TY - STD TI - Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2019 Global strategy for prevention, diagnosis and management of COPD [https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf]. UR - https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf ID - ref1 ER - TY - STD TI - Chronic obstructive pulmonary disease (COPD) [https://www.who.int/en/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)]. UR - https://www.who.int/en/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease- ID - ref2 ER - TY - JOUR AU - Riley, C. M. AU - Sciurba, F. C. PY - 2019 DA - 2019// TI - Diagnosis and outpatient Management of Chronic Obstructive Pulmonary Disease: a review JO - JAMA VL - 321 UR - https://doi.org/10.1001/jama.2019.0131 DO - 10.1001/jama.2019.0131 ID - Riley2019 ER - TY - JOUR AU - Tashkin, D. P. AU - Celli, B. AU - Senn, S. AU - Burkhart, D. AU - Kesten, S. AU - Menjoge, S. AU - Decramer, M. AU - Investigators, U. S. PY - 2008 DA - 2008// TI - A 4-year trial of tiotropium in chronic obstructive pulmonary disease JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0805800 DO - 10.1056/NEJMoa0805800 ID - Tashkin2008 ER - TY - JOUR AU - Rothnie, K. J. AU - Mullerova, H. AU - Smeeth, L. AU - Quint, J. K. PY - 2018 DA - 2018// TI - Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 198 UR - https://doi.org/10.1164/rccm.201710-2029OC DO - 10.1164/rccm.201710-2029OC ID - Rothnie2018 ER - TY - JOUR AU - Canning, B. J. PY - 2006 DA - 2006// TI - Reflex regulation of airway smooth muscle tone JO - J Appl Physiol (1985) VL - 101 UR - https://doi.org/10.1152/japplphysiol.00313.2006 DO - 10.1152/japplphysiol.00313.2006 ID - Canning2006 ER - TY - JOUR AU - Zaccone, E. J. AU - Undem, B. J. PY - 2016 DA - 2016// TI - Airway vagal neuroplasticity associated with respiratory viral infections JO - Lung VL - 194 UR - https://doi.org/10.1007/s00408-015-9832-5 DO - 10.1007/s00408-015-9832-5 ID - Zaccone2016 ER - TY - JOUR AU - Rogers, D. F. PY - 2001 DA - 2001// TI - Motor control of airway goblet cells and glands JO - Respir Physiol VL - 125 UR - https://doi.org/10.1016/S0034-5687(00)00209-7 DO - 10.1016/S0034-5687(00)00209-7 ID - Rogers2001 ER - TY - JOUR AU - Atanasova, K. R. AU - Reznikov, L. R. PY - 2018 DA - 2018// TI - Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis JO - Respir Res VL - 19 UR - https://doi.org/10.1186/s12931-018-0846-4 DO - 10.1186/s12931-018-0846-4 ID - Atanasova2018 ER - TY - JOUR AU - Slebos, D. J. AU - Klooster, K. AU - Koegelenberg, C. F. AU - Theron, J. AU - Styen, D. AU - Valipour, A. AU - Mayse, M. AU - Bolliger, C. T. PY - 2015 DA - 2015// TI - Targeted lung denervation for moderate to severe COPD: a pilot study JO - Thorax VL - 70 UR - https://doi.org/10.1136/thoraxjnl-2014-206146 DO - 10.1136/thoraxjnl-2014-206146 ID - Slebos2015 ER - TY - JOUR AU - Slebos, D. J. AU - Shah, P. L. AU - Herth, F. J. AU - Pison, C. AU - Schumann, C. AU - Hubner, R. H. AU - Bonta, P. I. AU - Kessler, R. AU - Gesierich, W. AU - Darwiche, K. PY - 2019 DA - 2019// TI - Safety and adverse events after targeted lung denervation for symptomatic moderate to severe COPD (AIRFLOW): a multicenter randomized controlled trial JO - Am J Respir Crit Care Med VL - 200 UR - https://doi.org/10.1164/rccm.201903-0624OC DO - 10.1164/rccm.201903-0624OC ID - Slebos2019 ER - TY - JOUR AU - Valipour, A. AU - Asadi, S. AU - Pison, C. AU - Jondot, M. AU - Kessler, R. AU - Benneddif, K. AU - Deslee, G. AU - Verdier, M. AU - Slebos, D. J. AU - Mayse, M. PY - 2018 DA - 2018// TI - Long-term safety of bilateral targeted lung denervation in patients with COPD JO - Int J Chron Obstruct Pulmon Dis VL - 13 UR - https://doi.org/10.2147/COPD.S158748 DO - 10.2147/COPD.S158748 ID - Valipour2018 ER - TY - JOUR AU - Vogelmeier, C. AU - Hederer, B. AU - Glaab, T. AU - Schmidt, H. AU - Rutten-van Molken, M. P. AU - Beeh, K. M. AU - Rabe, K. F. AU - Fabbri, L. M. AU - Investigators, P. -. C. PY - 2011 DA - 2011// TI - Tiotropium versus salmeterol for the prevention of exacerbations of COPD JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1008378 DO - 10.1056/NEJMoa1008378 ID - Vogelmeier2011 ER - TY - JOUR AU - Kistemaker, L. E. AU - Slebos, D. J. AU - Meurs, H. AU - Kerstjens, H. A. AU - Gosens, R. PY - 2015 DA - 2015// TI - Anti-inflammatory effects of targeted lung denervation in patients with COPD JO - Eur Respir J VL - 46 UR - https://doi.org/10.1183/13993003.00413-2015 DO - 10.1183/13993003.00413-2015 ID - Kistemaker2015 ER - TY - JOUR AU - Revicki, D. A. AU - Rentz, A. M. AU - Dubois, D. AU - Kahrilas, P. AU - Stanghellini, V. AU - Talley, N. J. AU - Tack, J. PY - 2004 DA - 2004// TI - Gastroparesis cardinal symptom index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms JO - Qual Life Res VL - 13 UR - https://doi.org/10.1023/B:QURE.0000021689.86296.e4 DO - 10.1023/B:QURE.0000021689.86296.e4 ID - Revicki2004 ER - TY - JOUR AU - Valipour, A. AU - Shah, P. L. AU - Pison, C. AU - Ninane, V. AU - Janssens, W. AU - Perez, T. AU - Kessler, R. AU - Deslee, G. AU - Garner, J. AU - Abele, C. PY - 2019 DA - 2019// TI - Safety and dose study of targeted lung denervation in moderate/severe COPD patients JO - Respiration VL - 98 UR - https://doi.org/10.1159/000499316 DO - 10.1159/000499316 ID - Valipour2019 ER - TY - JOUR AU - Halpin, D. M. M. M. AU - Metzdorf, N. AU - Celli, B. PY - 2017 DA - 2017// TI - Impact and prevention of severe exacerbations of COPD: a review of the evidence JO - Int J Chron Obstruct Pulmon Dis VL - 12 UR - https://doi.org/10.2147/COPD.S139470 DO - 10.2147/COPD.S139470 ID - Halpin2017 ER - TY - JOUR AU - Criner, G. J. AU - Connett, J. E. AU - Voelker, H. PY - 2014 DA - 2014// TI - Simvastatin in moderate-to-severe COPD JO - N Engl J Med VL - 371 ID - Criner2014 ER - TY - JOUR AU - Pavord, I. D. AU - Chanez, P. AU - Criner, G. J. AU - Kerstjens, H. A. M. AU - Korn, S. AU - Lugogo, N. AU - Martinot, J. B. AU - Sagara, H. AU - Albers, F. C. AU - Bradford, E. S. PY - 2017 DA - 2017// TI - Mepolizumab for Eosinophilic chronic obstructive pulmonary disease JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1708208 DO - 10.1056/NEJMoa1708208 ID - Pavord2017 ER - TY - JOUR AU - Han, M. K. AU - Quibrera, P. M. AU - Carretta, E. E. AU - Barr, R. G. AU - Bleecker, E. R. AU - Bowler, R. P. AU - Cooper, C. B. AU - Comellas, A. AU - Couper, D. J. AU - Curtis, J. L. PY - 2017 DA - 2017// TI - Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort JO - Lancet Respir Med VL - 5 UR - https://doi.org/10.1016/S2213-2600(17)30207-2 DO - 10.1016/S2213-2600(17)30207-2 ID - Han2017 ER - TY - JOUR AU - McGhan, R. AU - Radcliff, T. AU - Fish, R. AU - Sutherland, E. R. AU - Welsh, C. AU - Make, B. PY - 2007 DA - 2007// TI - Predictors of rehospitalization and death after a severe exacerbation of COPD JO - Chest VL - 132 UR - https://doi.org/10.1378/chest.06-3018 DO - 10.1378/chest.06-3018 ID - McGhan2007 ER - TY - JOUR AU - Guarascio, A. J. AU - Ray, S. M. AU - Finch, C. K. AU - Self, T. H. PY - 2013 DA - 2013// TI - The clinical and economic burden of chronic obstructive pulmonary disease in the USA JO - Clinicoecon Outcomes Res VL - 5 ID - Guarascio2013 ER - TY - JOUR AU - Lipson, D. A. AU - Barnhart, F. AU - Brealey, N. AU - Brooks, J. AU - Criner, G. J. AU - Day, N. C. AU - Dransfield, M. T. AU - Halpin, D. M. G. AU - Han, M. K. AU - Jones, C. E. PY - 2018 DA - 2018// TI - Once-daily single-inhaler triple versus dual therapy in patients with COPD JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1713901 DO - 10.1056/NEJMoa1713901 ID - Lipson2018 ER - TY - JOUR AU - Puhan, M. A. AU - Gimeno-Santos, E. AU - Cates, C. J. AU - Troosters, T. PY - 2016 DA - 2016// TI - Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease JO - Cochrane Database Syst Rev VL - 12 ID - Puhan2016 ER - TY - JOUR AU - Spitzer, K. A. AU - Stefan, M. S. AU - Priya, A. AU - Pack, Q. R. AU - Pekow, P. S. AU - Lagu, T. AU - Pinto-Plata, V. M. AU - ZuWallack, R. L. AU - Lindenauer, P. K. PY - 2019 DA - 2019// TI - Participation in pulmonary rehabilitation after hospitalization for chronic obstructive pulmonary disease among Medicare beneficiaries JO - Ann Am Thorac Soc VL - 16 UR - https://doi.org/10.1513/AnnalsATS.201805-332OC DO - 10.1513/AnnalsATS.201805-332OC ID - Spitzer2019 ER - TY - JOUR AU - Wedzicha, J. A. AU - Decramer, M. AU - Seemungal, T. A. PY - 2012 DA - 2012// TI - The role of bronchodilator treatment in the prevention of exacerbations of COPD JO - Eur Respir J VL - 40 UR - https://doi.org/10.1183/09031936.00048912 DO - 10.1183/09031936.00048912 ID - Wedzicha2012 ER - TY - JOUR AU - Beeh, K. M. AU - Hederer, B. AU - Glaab, T. AU - Muller, A. AU - Rutten-van Moelken, M. AU - Kesten, S. AU - Vogelmeier, C. PY - 2009 DA - 2009// TI - Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations JO - Int J Chron Obstruct Pulmon Dis VL - 4 ID - Beeh2009 ER - TY - JOUR AU - Wedzicha, J. A. AU - Decramer, M. AU - Ficker, J. H. AU - Niewoehner, D. E. AU - Sandstrom, T. AU - Taylor, A. F. AU - D'Andrea, P. AU - Arrasate, C. AU - Chen, H. AU - Banerji, D. PY - 2013 DA - 2013// TI - Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study JO - Lancet Respir Med VL - 1 UR - https://doi.org/10.1016/S2213-2600(13)70052-3 DO - 10.1016/S2213-2600(13)70052-3 ID - Wedzicha2013 ER -